Clinical
RSSArticles
-
A New Treatment for Recurrent Bacterial Vaginosis?
In this randomized, controlled trial of 228 women, Lactobacillus crispatus CTV-05 (Lactin-V) applied vaginally for 11 weeks reduced the incidence of recurrent bacterial vaginosis from 45% in the placebo arm to 30% in the Lactin-V arm.
-
Fezolinetant Shows Positive Response in Vasomotor Symptoms Associated with Menopause
A phase 2b trial using seven dosing regimens of a novel neurokinin-3 receptor antagonist, fezolinetant, shows statistically significant improvement in vasomotor symptoms vs. placebo in postmenopausal women.
-
Does a Standardized Recovery Bundle After Cesarean Delivery Decrease Length of Stay?
Implementation of an enhanced recovery bundle after cesarean delivery reflected diverse positive outcomes. However, length of stay was reduced only by an average of two hours.
-
Is RhoGAM Needed for Rh-Negative Women Experiencing First-Trimester Pregnancy Loss or Induced Abortion?
In this prospective cohort pilot study, the authors validated a flow cytometry protocol for detecting fetal red blood cells and determined that fetal red blood cell exposure in first-trimester uterine aspiration was well below the calculated threshold for maternal Rh sensitization.
-
COVID-19 Lockdown Measures May Have Prevented 530 Million Additional Infections
Researchers studied actions taken in six countries and the resulting outcomes.
-
Investigators Identify Connection Between Vascular Malformation, Gut Bacteria Profile
The presence of gram-negative bacteria was linked to an abundance of abnormalities known to cause strokes, seizures, and headaches.
-
Cannabis Use and Stroke Risk: The Debate Continues
A recently published paper suggests there may be no connection, but the conversation on this topic, as well as the general efficacy of medical marijuana, goes on.
-
We'd Love to Hear from You!
Please take five minutes to complete our annual user survey.
-
Study Reveals Low Rate of Contraceptive Use in Women with Recent Preterm Births
Medicaid claims data among a North Carolina cohort show that women were less likely to fill a contraceptive claim within 90 days after preterm birth. Investigators theorized it would be harder for women to access contraception after a preterm birth because they would be caring for a medically fragile infant. Also, women who deliver preterm experience shorter pregnancies, which means there is less time for a conversation with their healthcare providers about contraception.
-
Servicewomen Experience Barriers to Contraception
A follow-up survey of United States servicewomen and their access to contraceptives during their deployment revealed both good and bad news. Some women reported greater access to contraception, while others experienced barriers to obtaining contraceptives in the weeks leading up to their deployment.